GTPBP3 Gene: Mitochondrial tRNA Modification and Disease

Essential for mitochondrial translation and linked to combined oxidative phosphorylation deficiency

Gene Information Card

Symbol GTPBP3
Full Name GTP binding protein 3 (mitochondrial)
Gene Type Protein coding
Chromosomal Location 19p13.11
NCBI Gene ID 84705 ncbi.nlm.nih.gov/gene/84705
Ensembl ID ENSG00000130226
UniProt ID Q969Y2
OMIM ID 608536
HGNC ID 14880
Aliases GTPBG3, COXPD23, MTGP1

Description

The GTPBP3 gene encodes a mitochondrial GTP-binding protein that is essential for the post-transcriptional modification of mitochondrial tRNAs, specifically the 5-taurinomethyl modification of the wobble uridine base. This modification is critical for accurate and efficient mitochondrial translation. Mutations in GTPBP3 cause combined oxidative phosphorylation deficiency type 23 (COXPD23), a severe mitochondrial disorder characterized by hypertrophic cardiomyopathy, encephalopathy, and lactic acidosis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Combined oxidative phosphorylation deficiency 23 (COXPD23) Loss-of-function mutations impair mitochondrial tRNA modification, leading to defective mitochondrial protein synthesis and respiratory chain dysfunction. ClinVar, OMIM (OMIM: 616198)
Hypertrophic cardiomyopathy (secondary) Mitochondrial dysfunction due to GTPBP3 mutations causes energy deficiency in cardiac muscle, leading to hypertrophy. Case reports in PubMed (e.g., PMID: 25058215)
Encephalopathy / Leigh-like syndrome Impaired mitochondrial energy production affects the central nervous system, resulting in neurological symptoms. ClinVar, OMIM (OMIM: 616198)

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 12.1 Medium
Skeletal Muscle 8.9 Low
Liver 7.4 Low
Brain 6.2 Low
Kidney 5.8 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 10.5 Hepatocellular carcinoma cell line
K562 8.2 Chronic myelogenous leukemia
A549 7.9 Lung carcinoma
MCF7 6.8 Breast adenocarcinoma
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.950G>A (p.Arg317His) Missense Reported in COXPD23 patients Impairs GTPase activity and tRNA modification
c.475C>T (p.Arg159Trp) Missense Reported in COXPD23 patients Disrupts protein function
c.1075C>T (p.Arg359Trp) Missense Reported in COXPD23 patients Affects mitochondrial localization
c.137A>G (p.Tyr46Cys) Missense Reported in COXPD23 patients Reduces protein stability
Mutation functional classification

Loss of Function (LOF)

Most pathogenic mutations are loss-of-function, reducing GTPase activity or protein stability, leading to defective tRNA modification and mitochondrial translation.

Gain of Function (GOF)

No evidence of gain-of-function mutations in GTPBP3.

Dominant Negative (DN)

No evidence of dominant-negative effects; disease is inherited in an autosomal recessive manner.

Gene Ontology (GO)

• GTP binding • GTPase activity
• mitochondrial tRNA modification • mitochondrial translation
• tRNA binding • mitochondrion

Pathways

• Mitochondrial tRNA modification
• Mitochondrial translation
• Oxidative phosphorylation

Protein Summary

GTPBP3 is a nuclear-encoded mitochondrial protein that localizes to the mitochondrial matrix. It forms a heterodimer with MTO1 to catalyze the 5-taurinomethyl modification of the wobble uridine in mitochondrial tRNAs specific for Leu, Lys, Glu, and Gln. This modification is essential for proper codon-anticodon interactions and translational fidelity. Defects in GTPBP3 lead to impaired mitochondrial protein synthesis, causing respiratory chain deficiencies and clinical manifestations such as cardiomyopathy and encephalopathy.

Related Products

Product name Cat.No. Species Gene ID
GTPBP3 Knockout HEK293 Cell Line EDJ-KQ10174 Human 84705 Details Get a Quote
GTPBP3 Knockout HCT 116 Cell Line EDJ-KQ36049 Human 84705 Details Get a Quote
GTPBP3 Knockout A-549 Cell Line EDJ-KQ37283 Human 84705 Details Get a Quote
GTPBP3 Knockout HeLa Cell Line EDJ-KQ37285 Human 84705 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: